Throughout his career, Jan Van Deursen has championed diversity among faculty members, filling 5 out of the 6 tenure-track positions with diverse candidates. He worked with the leadership of Mayo Clinic to improve institutional support and mentoring programs for non-tenure-track faculty. Consequently, his research lab remained highly diverse throughout his tenure, and this diversity is a testament to his leadership. Read on to learn more about his accomplishments.
During his tenure at Mayo Clinic, DrJan Van Deursen uncovered how senescent cells accumulate in the body. These cells were previously believed to be harmless, but he discovered that the removal of these cells lengthened the mice’s lives and attenuated various ageing-related diseases. This discovery led Jan Van Deursen to co-found Unity Biotechnology, which is currently developing a drug to remove senescent cells from human cells. His company is gearing up for clinical trials for glaucoma and osteoarthritis, and he’s now a part-time researcher at Unity Biotechnology.
After graduating from the University of Nijmegen, Dr. van Deursenestablished his laboratory. He worked with Dr Be Wieringa, his advisor at the time. Van Deursen’s research focused on the regulation of nuclear-cytoplasmic transport. He has published many papers in renowned scientific journals, and the National Institutes of Health have funded several of his studies.
In addition to his research at Mayo Clinic, Jan Van Deursen mentored dozens of young scientists pursuing careers in science. His mentorship of these scientists helped Dr Childs become a successful physician-scientist. Jan Van Deursen’s research helped Dr Childs to become an internationally renowned physician-scientist. It’s no wonder that he is considered a mentor in the field of biochemistry.
In June, the Mayo Clinic offered Dr Van Deursen a five-year contract that would have paid $27,000 per month. However, the clinic denied recruiting van Deursen until early August 2020. The case is currently being investigated. In the meantime, a German blogger has reported allegations of bullying. The Mayo Clinic will respond to the lawsuit in court. The lawsuit filed by Van Deursen will continue to pursue damages against the Mayo Clinic.
In 2000, Jan Van Deursen earned his PhD in cell biology from the University of Nijmegen in the Netherlands. He later moved to the United States and worked at the Mayo Clinic in Rochester, Minnesota, where he made his breakthrough discovery. A renowned scientist, Jan Van Deursen’s work is being pursued by many. The breakthrough has resulted in innovative treatments for age-related diseases, which could help countless people.
Dr Jan Van Deursen’s research has been cited as a breakthrough in cardiovascular disease, showing that removing senescent cells from the body may prolong life. Several recent publications support this research. Dr Van Deursen’s research has been published in the journals Nature and Science, where he is now chair of the Department of Pediatrics. He received his predoctoral fellowship from the National Heart, Lung, and Blood Institute.
Among the technologies that Jan Van Deursen has developed and applied to cancer research, he has discovered that the essential mitotic checkpoint protein BubR1 is responsible for faithful chromosome segregation. This research has to lead to the development of therapeutics to address the underlying causes of age-related disease. There are many more discoveries to come, but he has the most significant ones for now. In his laboratory, Dr Jan Van Deursen earned the Nobel Prize for his work.
Dr Van Deursen is a pioneer in the field of cell biology. He is an expert in identifying the senescent cells that accumulate in the body as humans age. He is responsible for the development of mouse models for cancer. His research on senescent cells led to a breakthrough in the treatment of ageing. Although the study has not eliminated the senescent cells, it does eliminate 50% to 70% of them in some tissues.
